Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis
Clinical trial NCT06005792 · TERMINATED
Trial details
- NCT number
- NCT06005792
- Sponsor
- Xencor, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2024-03-22
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.